Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

365
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
365
Introduction Cardiac Emergencies01:30

Introduction Cardiac Emergencies

234
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
234
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

246
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
246
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

756
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
756
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

278
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
278
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

201
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
201

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bone morphogenetic protein 10: clinical correlates and risk of incident atrial fibrillation.

American journal of physiology. Heart and circulatory physiology·2025
Same author

Small-molecule-induced ERBB4 activation to treat heart failure.

Nature communications·2025
Same author

Monitoring and modulating cardiac bioelectricity: from Einthoven to end-user.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2024
Same author

'Trapped re-entry' as source of acute focal atrial arrhythmias.

Cardiovascular research·2023
Same author

Sbk2, a Newly Discovered Atrium-Enriched Regulator of Sarcomere Integrity.

Circulation research·2022
Same author

Conditional immortalization of human cardiomyocytes for translational in vitro modelling of cardiovascular disease.

Cardiovascular research·2022

Related Experiment Video

Updated: Dec 14, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K

SARS-CoV-2/COVID-19: a primer for cardiologists.

A A F de Vries1

  • 1Laboratory of Experimental Cardiology, Department of Cardiology, Leiden University Medical Centre, Leiden, The Netherlands. a.a.f.de_vries@lumc.nl.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|July 17, 2020
PubMed
Summary

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic caused a global health crisis. This review details SARS-CoV-2, COVID-19 clinical features, diagnostics, and potential treatments.

Keywords:
Acute respiratory distress syndromeAntiviral drugCoronavirus disease 2019PandemicSevere acute respiratory syndrome coronavirus 2Vaccine

More Related Videos

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

1.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Related Experiment Videos

Last Updated: Dec 14, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
08:41

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2

Published on: November 5, 2021

3.2K
Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP
05:34

Author Spotlight: Advancing Pathogen Diagnostics with Standardized LAMP

Published on: September 8, 2023

1.1K
Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
03:53

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses

Published on: November 10, 2023

1.7K

Area of Science:

  • Virology
  • Immunology
  • Epidemiology

Background:

  • The emergence of SARS-CoV-2 in 2019 initiated a global pandemic, causing severe health and socioeconomic impacts.
  • COVID-19, the disease caused by SARS-CoV-2, exhibits variable severity, ranging from asymptomatic cases to critical illness.
  • The zoonotic origin and rapid transmission of SARS-CoV-2 underscore the need for comprehensive understanding.

Purpose of the Study:

  • To provide a comprehensive overview of the SARS-CoV-2 life cycle and transmission dynamics.
  • To describe the clinical and immunological characteristics of COVID-19.
  • To review current diagnostic methods, therapeutic strategies, and vaccine development for COVID-19.

Main Methods:

  • Literature review of virological assays for SARS-CoV-2 detection.
  • Analysis of serological tests for SARS-CoV-2-specific antibody detection.
  • Overview of therapeutic approaches including antivirals, immunomodulators, and anticoagulants.

Main Results:

  • Detailed description of the SARS-CoV-2 life cycle and transmission pathways.
  • Characterization of diverse clinical presentations and immunological responses in COVID-19 patients.
  • Summary of advancements in diagnostic testing and therapeutic interventions.

Conclusions:

  • Ongoing research and technological advancements offer hope for effective treatments and vaccines against COVID-19.
  • Despite progress, COVID-19 is expected to have a lasting societal impact.
  • Further understanding of SARS-CoV-2 is crucial for future pandemic preparedness.